Back to evidence
Regulatory record

RelieVRx FDA 510(k) Summary — K243417

FDA summary describing RelieVRx, its intended use, device classification, and relationship to the predicate device.

Source reviewed
Structured overview

What this record covers

GeographyUnited States
ModalitiesVR
StagePublic record
Last reviewed2026-07-23

Clinical areas and use cases

Specialties

Pain management

Use cases

Regulatory referenceTherapy support
Provenance

Primary source

U.S. Food and Drug AdministrationCitation metadata and short AVRMD summary; source document is not republished.
Questions should improve the record.

Community Q&A will be scoped here while moderation stays independent of page owners.